Company Overview of Mills Pharmaceuticals, LLC
Mills Pharmaceuticals, LLC designs and develops active ingredient anagrelide, GALE-401 (Anagrelide CR) used for treatment of Essential Thrombocythemia (ET). The company is based in the United States. As of January 12, 2014, Mills Pharmaceuticals, LLC operates as a subsidiary of Galena Biopharma, Inc.
Key Executives for Mills Pharmaceuticals, LLC
Mills Pharmaceuticals, LLC does not have any Key Executives recorded.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
To contact Mills Pharmaceuticals, LLC, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.